The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection
ecancermedicalscience · 03.02.2026 · 20
DOI: 10.3332/ecancer.2026.2071 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ecancermedicalscience, online erschienen am 03.02.2026. Verfasst von Charles M Balch und 59 weiteren Autor:innen. Beteiligte Einrichtung: UT MD Anderson Cancer Center, Houston, TX 77030, USA. Die Arbeit wurde bisher 21-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: World Health Organization.
Abstract (Originalsprache)
Cancer constitutes one of the most urgent global health crises, with over 20 million new cases diagnosed annually worldwide, claiming 10 million lives. This devastating burden disproportionately affects vulnerable populations: 75% of cancer deaths occur in low- and middle-income countries despite these regions having lower reported incidence rates. Lung cancer leads the global toll, representing 12% of all cases but 19% of deaths, followed by breast cancer (12% of cases) and colorectal cancer (9.6%). A stark geographical inequity defines the cancer landscape-while wealthy regions such as North America, Northern Europe and Australia report the highest incidence rates, Africa and Latin America suffer the highest mortality rates. This disparity will intensify dramatically: cancer deaths in low-income countries are projected to surge 155% compared to just 56% in high-income nations by 2050. The financial devastation compounds this crisis, with 56% of patients worldwide facing catastrophic health expenditures extending beyond medical costs to include lost income and reduced productivity. Economic burden varies starkly by wealth: 75% of patients in low-income countries experience financial catastrophe versus 58% in middle-income countries and 26% in high-income nations. However, cancer prevention offers unprecedented opportunities to transform this crisis through interventions we already possess. From largely preventable infectious cancers like stomach and cervical malignancies, to lifestyle-driven epidemics including lung and colorectal cancers, to complex multifactorial diseases like breast cancer. Evidence-based prevention strategies can dramatically reduce suffering while generating massive healthcare savings. Emerging genetic technologies amplify this potential: universal genetic testing and pharmacogenomics now enable identification of high-risk individuals before disease develops, allowing targeted prevention while optimising treatments based on individual genetic profiles. Cancer prevention represents not merely a health opportunity but an economic imperative. The primary barrier is no longer scientific understanding but systematic implementation. Governments, policymakers, insurance companies and the public urgently need clearer evidence and education demonstrating proven successes to motivate decisive action toward creating healthier populations and reducing cancer burdens worldwide.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UT MD Anderson Cancer Center, Houston, TX 77030, USA.
- Guangdong Provincial People's Hospital, Guangzhou 510080, China.
- Health Hope Pharma, Hong Kong SAR, China.
- University of Kansas Comprehensive Cancer Center, Kansas City, KS 66160, USA.
- Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
- University College Cancer Institute, London, WC1E 6DD, UK.
Förderung
- World Health Organization
Zitieren
APA
Balch, C. M., Liao, N., Lam, D. S. C., Weitzel, J. N., Xu, R. H., Attard, G., Bunn, P. A., Eggermont, A. M. M., He, J., Kitagawa, Y., Lim, S. T., Cazap, E., Esquivel, B., Fan, X., Chow, L. W. C., Liu, E. S. F., Said, H. M., Niederhuber, J. E., Rubio, I. T., …, & Soerjomataram, I. (2026). The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection. ecancermedicalscience, 20. https://doi.org/10.3332/ecancer.2026.2071
Vancouver
Balch CM, Liao N, Lam DSC, Weitzel JN, Xu RH, Attard G, et al. The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection. ecancermedicalscience. 2026;20. doi:10.3332/ecancer.2026.2071
BibTeX
@article{Balch2026,
author = {Balch, Charles M and Liao, Ning and Lam, Dennis S C and Weitzel, Jeffrey N and Xu, Rui-Hua and Attard, Gerhardt and Bunn, Paul A and Eggermont, Alexander M M and He, Jie and Kitagawa, Yuko and Lim, Soon Thye and Cazap, Eduardo and Esquivel, Bernard and Fan, Xianqun and Chow, Louis W C and Liu, Edward S F and Said, Hector Martinez and Niederhuber, John E and Rubio, Isabel T and Zaghloul, Ashraf Saad and Arrieta, Oscar G and Audisio, Riccardo A and Beets, Geerard L and Coimbra, Felipe J F and Gallardo, Jorge E and Garber, Judy E and Gronchi, Alessandro and Heinemann, Volker and Kurian, Allison W and Mutebi, Miriam and Mori, Masaki and Olopade, Funmi I and Rutkowski, Piotr and Saleh, Mansoor and Sanchez, William M and Sawaya, Raymond and Thompson, John F and Tumusiime, Gerald and Vallejos, Carlos S and Whiteman, David C and Wu, YiLong and Yawe, King-David T and Zahrani, Nayef Awad Al and Zoras, Odysseas and Arun, Banu K and Fabian, Carol J and Gershenwald, Jeffrey E and Gradishar, William J and He, Jin and Kimberg, V Suzanne and Lam, Ronald M K and Lee, Victor H F and Lorusso, Domenica and Mok, Tony S K and Perrier, N D and Rugo, Hope S and Ulrich, Cornelia and Are, Chandrakanth and Vignat, J and Soerjomataram, I},
title = {The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection},
journal = {ecancermedicalscience},
year = {2026},
volume = {20},
doi = {10.3332/ecancer.2026.2071}
}
EUVIMED